Dr. Phillip Schmitz Moore, MD

Dr. Moore practices at Novant Health Vascular Diagnostics in Winston Salem, North Carolina.

Dr. Moore's NPI, 1215119151, was assigned on December 3, 2007. Dr. Moore graduated from Wake Forest School of Medicine in 2002. Dr. Moore's North Carolina license number on file is 2008-01396.

Dr. Moore's primary practice is Novant Health Vascular Diagnostics, at 2827 Lyndhurst Ave, Winston Salem, NC 27103 in Forsyth County. The practice phone is (336) 768-5445.

Dr. Moore's primary practice is Novant Health Vascular Diagnostics in Winston Salem, North Carolina. Dr. Moore is also affiliated with Novant Health Forsyth Medical Center. The medical group on file is Novant Health Indian Land Primary Care. Dmand AI also links Dr. Moore to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moore practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Moore's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Moore is board certified in vascular surgery by the American Board of Surgery. Dr. Moore has a license on file in North Carolina.

Dmand AI lists amputation, aortic atherosclerois, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, heart device and aorta surgery and leg revascularization among the conditions Dr. Moore treats.

CMS data shows 721 Medicare services from Dr. Moore across 17 procedure codes in 2024, for 513 Medicare patients. Medicare paid $71,365 for them.

CMS counts 513 Medicare patients who saw Dr. Moore in 2024. The largest group is 65 to 74, with 230 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moore's median patient age at 72, with 49% women.

In 2024, Dr. Moore wrote 487 Medicare Part D claims for 147 patients. 72% of them were for generic drugs. CMS names the drug for 405 of them, across 8 drugs with 11 or more claims each, at $103,442 in total drug cost. In 2023, CMS named 381 claims across 9 drugs.

Dr. Moore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of leg revascularization (restoring blood flow) by Dr. Moore, more than 81% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Moore, published from 2006 to 2010. 2010 was the busiest year, with 2. The most frequent topics are Kidney Transplantation, Graft Rejection and Graft Survival. Dr. Moore has published most often in J Vasc Surg. Dr. Moore's most frequent co-authors are Alan Christopher Farney, MD and John R. Hoyle, MD.

CMS Open Payments shows 107 general payments to Dr. Moore from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. Nuvasive, Inc. paid the most, $989.

Dmand AI lists 1 award for Dr. Moore, most recently CMS Stage 1 EHR in 2013.

Dr. Moore graduated from Wake Forest School of Medicine in 2002. Dr. Moore is a member of SVS.

Dr. Moore is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.